Pharmaceutical preparations company · WY · FY ends Mar · Revenue $0.00
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$0.00
▼ -100.0% YoY
Net Income (TTM)
$33.00
▲ +59.2% YoY
Op. Margin
—
ROIC
8.69%
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (FY)
-$45K
▲ +56.7% YoY
Net Debt
-$300.00
Net Cash Position
Cash & Equiv.
$300.00
Continue Research